Cancer de la prostate: les marqueurs biologiques

Citations of this article
Mendeley users who have this article in their library.
Get full text


Normal prostate cells and prostate cancer cells produce prostate-specific antigen (PSA): thus, it is frequently increased in non-malignant conditions such as prostatitis and benign prostatic hyperplasia. Indeed, PSA is an excellent biomarker to monitor disease progression. The low diagnostic specificity of PSA leads to many false-positive and a large number of biopsies. These well-recognized limitations of PSA suggest that new prostate cancer biomarkers could play a useful role in reducing the number of unnecessary biopsies. © 2011 Elsevier Masson SAS.




Gauchez, A. S. (2011, June). Cancer de la prostate: les marqueurs biologiques. Medecine Nucleaire.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free